Cargando…

Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods

BACKGROUND: Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state‐of‐the‐art. AIM: To describe differences of MDTMs by tumour type. METHODS: Twelve multidisciplinary team meetings (MDTMs) with participation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hitz, Felicitas, Ribi, Karin, Grote, Gudela, Kolbe, Michaela, Schmitz, Christof, Lamb, Benjamin W., Ruhstaller, Thomas, Berchtold, Peter, Sevdalis, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351662/
https://www.ncbi.nlm.nih.gov/pubmed/34582132
http://dx.doi.org/10.1002/cnr2.1541
_version_ 1784762482482479104
author Hitz, Felicitas
Ribi, Karin
Grote, Gudela
Kolbe, Michaela
Schmitz, Christof
Lamb, Benjamin W.
Ruhstaller, Thomas
Berchtold, Peter
Sevdalis, Nick
author_facet Hitz, Felicitas
Ribi, Karin
Grote, Gudela
Kolbe, Michaela
Schmitz, Christof
Lamb, Benjamin W.
Ruhstaller, Thomas
Berchtold, Peter
Sevdalis, Nick
author_sort Hitz, Felicitas
collection PubMed
description BACKGROUND: Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state‐of‐the‐art. AIM: To describe differences of MDTMs by tumour type. METHODS: Twelve multidisciplinary team meetings (MDTMs) with participation of different cancer disease specialists at a tertiary hospital were assessed by an exploratory sequential mixed method approach with interviews, observations and a survey to address the following five topics: organisational structure and supporting technology; leadership; teamwork; decision‐making, perceived value and motivation. Thirteen persons with different tumour specialities and levels of seniority were interviewed. The 12 MDTMs were observed twice by uninvolved persons and evaluated by the participating physicians with a survey. RESULTS: There were no systematic differences between MDTMs for different tumour types with the exception of the non‐disease specific type MDTM, which was the only one for which the organisational structure was not driven by an electronic tool. However, several factors could be identified that generally influenced the functioning of the MDTMs. In particular, the quality of decision‐making was highly dependent on the availability of case‐based information and the presence of relevant cancer disease specialists. Leadership and teamwork were rated as important and were comparable across the MDTM. Team participants' motivation and perceived value of MDTMs was high across all meetings. CONCLUSION: MDTM at a single institution did not demonstrate disease specific characteristics. An effective MDTM, irrespective of the tumour type, can be successfully structured by technical means and a chairperson coordinating the interaction of cancer disease specialists to improve the decision‐making process.
format Online
Article
Text
id pubmed-9351662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93516622022-08-09 Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods Hitz, Felicitas Ribi, Karin Grote, Gudela Kolbe, Michaela Schmitz, Christof Lamb, Benjamin W. Ruhstaller, Thomas Berchtold, Peter Sevdalis, Nick Cancer Rep (Hoboken) Original Articles BACKGROUND: Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state‐of‐the‐art. AIM: To describe differences of MDTMs by tumour type. METHODS: Twelve multidisciplinary team meetings (MDTMs) with participation of different cancer disease specialists at a tertiary hospital were assessed by an exploratory sequential mixed method approach with interviews, observations and a survey to address the following five topics: organisational structure and supporting technology; leadership; teamwork; decision‐making, perceived value and motivation. Thirteen persons with different tumour specialities and levels of seniority were interviewed. The 12 MDTMs were observed twice by uninvolved persons and evaluated by the participating physicians with a survey. RESULTS: There were no systematic differences between MDTMs for different tumour types with the exception of the non‐disease specific type MDTM, which was the only one for which the organisational structure was not driven by an electronic tool. However, several factors could be identified that generally influenced the functioning of the MDTMs. In particular, the quality of decision‐making was highly dependent on the availability of case‐based information and the presence of relevant cancer disease specialists. Leadership and teamwork were rated as important and were comparable across the MDTM. Team participants' motivation and perceived value of MDTMs was high across all meetings. CONCLUSION: MDTM at a single institution did not demonstrate disease specific characteristics. An effective MDTM, irrespective of the tumour type, can be successfully structured by technical means and a chairperson coordinating the interaction of cancer disease specialists to improve the decision‐making process. John Wiley and Sons Inc. 2021-09-28 /pmc/articles/PMC9351662/ /pubmed/34582132 http://dx.doi.org/10.1002/cnr2.1541 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Hitz, Felicitas
Ribi, Karin
Grote, Gudela
Kolbe, Michaela
Schmitz, Christof
Lamb, Benjamin W.
Ruhstaller, Thomas
Berchtold, Peter
Sevdalis, Nick
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods
title Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods
title_full Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods
title_fullStr Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods
title_full_unstemmed Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods
title_short Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods
title_sort team functioning across different tumour types: insights from a swiss cancer center using qualitative and quantitative methods
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351662/
https://www.ncbi.nlm.nih.gov/pubmed/34582132
http://dx.doi.org/10.1002/cnr2.1541
work_keys_str_mv AT hitzfelicitas teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT ribikarin teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT grotegudela teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT kolbemichaela teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT schmitzchristof teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT lambbenjaminw teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT ruhstallerthomas teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT berchtoldpeter teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods
AT sevdalisnick teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods